Fabrazyme and Bundle branch block right - a phase IV clinical study of FDA data

Summary:

Bundle branch block right is reported as a side effect among people who take Fabrazyme (agalsidase beta), especially for people who are male, 50-59 old, have been taking the drug for 1 - 6 months also take Lipitor, and have Fabry's disease.

The phase IV clinical study analyzes which people have Bundle branch block right when taking Fabrazyme. It is created by eHealthMe based on reports of 10,390 people who have side effects when taking Fabrazyme from the FDA, and is updated regularly.

What is Fabrazyme?

Fabrazyme has active ingredients of agalsidase beta. eHealthMe is studying from 10,406 Fabrazyme users. Check the latest studies of Fabrazyme.

What is Bundle branch block right?

Bundle branch block right (absence of transmission of electric impulses from the atrioventricular (av) bundle of his to the right ventricle) is found to be associated with 763 drugs and 895 conditions by eHealthMe. Check the latest studies of Bundle branch block right.

On Jul, 13, 2026

10,390 people reported to have side effects when taking Fabrazyme.
Among them, 18 people (0.17%) have Bundle branch block right.

Could Fabrazyme cause Bundle branch block right?

Among these 18 people:

How long have people been on Fabrazyme when they have Bundle branch block right? *

What is the gender of people who have Bundle branch block right when taking Fabrazyme? *

female: 35.29 %
male: 64.71 %

What is the age of people who have Bundle branch block right when taking Fabrazyme? *

What are other drugs people take besides Fabrazyme? *

What are other side effects people have besides Bundle branch block right? *

Mitral Valve Incompetence (inefficient heart valve): 8 people, 44.44%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 6 people, 33.33%
Left Ventricular Hypertrophy (the thickening of the myocardium (muscle) of the left ventricle of the heart): 6 people, 33.33%
Bundle Branch Block Left (absence of transmission of electric impulses from the atrioventricular (av) bundle of his to the left ventricle): 5 people, 27.78%
Tricuspid Valve Incompetence (inefficient heart valve): 5 people, 27.78%
Bradycardia (abnormally slow heart action): 4 people, 22.22%
Cardiac Failure Congestive: 4 people, 22.22%
Nausea (feeling of having an urge to vomit): 4 people, 22.22%
Pain In Extremity: 3 people, 16.67%
Dizziness: 3 people, 16.67%

What are the existing conditions these people have? *

Fabry's Disease (build up of a particular type of fat, called globotriaosylceramide, in the body's cells): 18 people, 100.00%

* Approximation only. Some reports may have incomplete information.

Do you take Fabrazyme and have Bundle branch block right?

- Check whether Bundle branch block right is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Fabrazyme:

Fabrazyme (10,406 reports)

Browse all side effects of Fabrazyme:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Bundle branch block right:

Bundle branch block right (763 drugs)

Browse all the conditions that are associated with Bundle branch block right:

Bundle branch block right (895 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on agalsidase beta (the active ingredients of Fabrazyme) and Fabrazyme (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.